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Abstract
Localized 13C nuclear magnetic resonance (NMR) spectroscopy provides a unique window for studying cerebral carbohydrate metabolism
through, e.g. the completely non-invasive measurement of cerebral glucose and glycogen metabolism. In addition, label incorporation into
amino acid neurotransmitters such as glutamate (Glu), GABA and aspartate can be measured providing information on Krebs cycle flux and
oxidative metabolism. Given the compartmentation of key enzymes such as pyruvate carboxylase and glutamine synthetase, the detection
of label incorporation into glutamine indicated that neuronal and glial metabolism can be measured in vivo. The purpose of this paper is
to provide a critical overview of these recent advances into measuring compartmentation of brain energy metabolism using localized in
vivo 13C NMR spectroscopy. The studies reviewed herein showed that anaplerosis is significant in brain, as is oxidative ATP generation in
glia and the rate of glial glutamine synthesis attributed to the replenishment of the neuronal Glu pool and that brain glycogen metabolism
is slow under resting conditions. This new modality promises to provide a new investigative tool to study aspects of normal and diseased
brain hitherto unaccessible, such as the interplay between glutamatergic action, glucose and glycogen metabolism during brain activation,
and the derangements thereof in patients with hepatic encephalopathy, neurodegenerative diseases and diabetes. © 2002 Elsevier Science
Ltd. All rights reserved.
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1. Introduction
In the traditional context of neuroscience the brain’s
tasks are mainly accomplished by the neurons, with the
surrounding glial cells having a rather passive function in
neurotransmission. However, the glial cells are more than
just passive components in neuronal function in that they
are intimately involved in the process of neurotransmis-
sion through, e.g. glial uptake of glutamate (Glu) from the
synaptic cleft (Yudkoff et al., 1993; Zigmond, 1999). Glu is
the major excitatory neurotransmitter (Shank and Aprison,
1979) which is present in the mammalian brain in high
concentrations. Despite the high intracellular concentration
of Glu, the extracellular concentration must be maintained
very low (∼0.004 mM) to avoid excitotoxicity. Presynap-
tic release of Glu into the synaptic cleft therefore requires
efficient uptake mechanisms, which are achieved by Glu
transporters (Arriza et al., 1994). Most of the metabolic
evidence suggests that uptake by glia is an important pro-
cess which has lead to the concept of the Glu–glutamine
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cycle (Brand et al., 1997; Westergaard et al., 1995;
Yudkoff et al., 1988). Recent studies have again supported
the participation of glia in neurotransmission through rapid
clearance of Glu from the synaptic cleft into neighboring
glia, based on conductance currents associated with Glu
uptake (Bergles et al., 1997) and consequent metabolism to
glutamine. The uptake of Glu into the astrocytes is asso-
ciated with increased glucose metabolism (Eriksson et al.,
1995; Magistretti et al., 1993), thereby linking stimulated
energy metabolism between glial and neuronal cells during
neurotransmission. This paper reviews recent contributions
of in vivo nuclear magnetic resonance (NMR) spectroscopy
to the assessment of neurotransmitter metabolism.
2. Features of 13C NMR spectroscopy in vivo and
relationship to other modalities
The administration of a tracer, whether stable or ra-
dioactive, and the ability to follow its metabolism provides
neurochemists and neuroscientists alike tools to study in
vivo metabolism non-invasively. When using radiotracers,
label in different metabolic pools cannot be distinguished,
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which has led to the use of non-metabolizable analogs, such
as deoxy-glucose. On the other hand, tracer studies can be
performed using stable isotopes. In conjunction with the
non-invasive detection using NMR the metabolism of stable
isotopes can be followed, although administration of the
“tracer” requires a higher enrichment. Because NMR spec-
troscopy can be used to detect label in different molecules
and different chemical positions, it offers the attractive
possibility to follow metabolism of the native compound,
labeled at one or more specific positions. For example, glu-
cose can be labeled at the 1 position and flow of the label
into metabolic pools further downstream can be followed
non-invasively. Applications are predominantly focused on
areas where a stable isotope is present at low natural abun-
dance, examples include 2H, 15N, 19F and 13C, the latter of
which shall be dealt with in this review.
Ideally, an investigative method applied to biomedical
problems is fully developed and “mature”. Unfortunately,
the development of 13C NMR spectroscopy in vivo has been
limited to a handful sites worldwide (Bluml, 1999; Chen
et al., 2001; Gruetter et al., 1998a; Rothman et al., 1999)
and largely requires further development, as biomedical
problems in general and neurochemical questions in par-
ticular develop. When considering these constraints in the
application of this method, it is clear that methodological
advances are likely required and expected when developing
the biomedical questions. This shall in the following be illus-
trated with a historical perspective on the development of the
application to the intact in vivo brain: The first application
of 13C MRS to the head (Behar et al., 1986), was admittedly
struggling with achieving the necessary spectral resolution
in vivo to separate the glutamine from the Glu resonances in
vivo. In retrospect, it is clear from the detection of intense
lipid signals in this and other early in vivo papers on the
brain, that signals from outside the brain were dominant,
such as the intense resonances from natural abundance lipids
(Beckmann et al., 1991; Behar et al., 1986; Bluml, 1999;
Sibson et al., 1997). In brain, the concentration of mobile
lipids is generally too low to be detected in vivo (although
this can be done in extracts) and therefore, the lipid reso-
nances seen in 13C NMR spectra of the head must be at-
tributed to extra-cerebral fat tissue, such as subcutaneous fat.
In 1991, it was shown for the first time that glucose can be ad-
ministered to humans, and resonances from Glu (Beckmann
et al., 1991; Rothman et al., 1985; Rothman et al., 1992)
and glucose (Gruetter et al., 1992a; Mason et al., 1992a)
were detected following 13C-labeled glucose administra-
tion. Most of these early studies continued to be hampered
by the lack of adequate spectral resolution and/or localiza-
tion. In 1992, two important advances in MR methodology
were introduced to in vivo 13C NMR spectroscopy: First,
the use of automated shimming (i.e. in vivo optimization
of the main static magnetic field, B0, such that it becomes
largely independent of the spatial coordinates) dramatically
improved sensitivity by narrowing linewidths by almost an
order of magnitude (Gruetter, 1993; Gruetter and Boesch,
1992). Second, the introduction of three-dimensional local-
ization allowed for well-defined volumes to be measured
(Gruetter et al., 1992a; Gruetter et al., 1992b). Two im-
mediate advances were immediately realizable, namely the
complete elimination of the intense scalp lipid signals from
the extra-cerebral tissue, which overlap with numerous sig-
nals from amino acids, and the collection of signals from
a well-defined volume together with excellent shimming
improved the spectral resolution. The improvements in sen-
sitivity were demonstrated with the rather surprising obser-
vation that natural abundance signals from brain metabolites
can be observed in vivo, such as those from myo-inositol
(Gruetter et al., 1992b). Also in 1992, these methodological
advances lead to the landmark discovery that labeling of glu-
tamine can be detected in the in vivo brain (Gruetter, 1993;
Gruetter et al., 1994), which is now recognized as a window
to study cerebral metabolic compartmentation (Bachelard,
1998; Cruz and Cerdan, 1999; Magistretti et al., 1999; Roth-
man et al., 1999). These advances have placed the 13C NMR
method into the neuroscience theater to provide a unique in
vivo window on the brain. NMR spectroscopy itself holds
promise to studying a number of neurochemical events that
are otherwise inaccessible by non-invasive means, and thus
opens the potential to study neurochemistry in patients.
A discussion of methodological issues surrounding the
use of 13C NMR in vivo would be incomplete without
the side-by-side comparison of the two principal detection
methods available, namely direct and indirect detection.
Direct detection of the 13C signals takes advantage of
the large chemical shift dispersion of the 13C nucleus. In
addition, the spin physics of the 13C nucleus are rather
simple, provided 1H decoupling is applied (Gruetter et al.,
1996). However, the increased specificity of direct detection
comes at the price of a substantial loss of sensitivity (Chen
et al., 1998). For example, the signal-to-noise ratio from an
equimolar solution at a given static field B0 can be as much
as 12-fold weaker for 13C than the corresponding 1H signal
in vivo. It is, therefore, attractive to exploit the fact that
1H nuclei in close chemical proximity to a 13C nucleus are
coupled through the heteronuclear J coupling, which with
appropriate “spin gymnastics” can be exploited to filter the
magnetization of those protons that are attached to a carbon
nucleus (Hyder et al., 1997; Pan et al., 1997; Pfeuffer et al.,
1999; Rothman et al., 1985; Schupp et al., 1993; Van Zijl
et al., 1993). The ensuing “13C-edited” 1H spectrum stands
to benefit from the improved sensitivity of 1H NMR. It also
stands to suffer from the same shortcoming, namely the
limited spectral dispersion, as the corresponding chemical
shifts in biomedical applications are crammed into a 10-fold
reduced bandwidth compared to carbon and additional ef-
forts are required to achieve adequate spectral resolution
(Watanabe et al., 2000).
The spectral resolution is especially limiting at low mag-
netic fields, such as the widely deployed magnetic field of
1.5 T, which does not allow the accurate separation of reso-
nances of Glu and glutamine. When increasing the magnetic
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Fig. 1. Illustration of the information content achievable in vivo by 13C and 1H-detected 13C NMR at 9.4 T. (A) is a direct-detected 13C NMR spectrum
from a 500l volume in approximately 1 h and is from Choi et al., 2000. In addition to the resonances from the amino acids, label incorporation into
the Glu C4 resonance of glutathione (GSH) was detected. For resonance assignments, see Fig. 2. (B) is a 1H NMR spectrum obtained from a 130l
volume in the rat brain in the first 1 h of glucose infusion showing resonances coupled to 13C only and is taken from Pfeuffer et al., 1999. The improved
sensitivity allowed the detection of label incorporation into alanine C3 (Ala). Natural abundance signal is detected for creatine (Crtot) and NAA.
Fig. 2. 13C NMR detection of label incorporation into cytosolic amino acids in a 45 ml volume in the human occipital lobe at 4 T, from Gruetter et al.,
2001. Shown is a representative spectrum obtained from a 3 cm × 3 cm × 5 cm volume in the human visual cortex in 45 min. Resonance assignments
are as follows: Glu C2 at 55.6 ppm, Gln C2 at 55.0 ppm, NAA C2 at 54.0 ppm, Asp C2 at 53.7 ppm, NAA C3 at 40.5 ppm, GABA C4 at 40.45 ppm,
Asp C3 at 37.6 ppm, GABA C2 at 35.3 ppm, Glu C4 at 34.2 ppm, Gln C4 at 31.7 ppm, Glu C3 at 28.0 ppm Gln C3 at 27.7 ppm. In addition to these
resonances, resonances ascribed to the homonuclear 13C–13C coupling were readily detected at the positions of all Glu resonances (brackets).
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field some of these limitations can be overcome due to im-
proved spectral dispersion (Gruetter et al., 1998c), allowing
the detection of resolved signals from 13C labeled Glu and
glutamine by 1H NMR spectroscopy (Pfeuffer et al., 1999).
Fig. 1A illustrates that the resonances of most amino acids in
13C NMR spectra are easily resolved, whereas in 1H NMR
spectra the resolution of a number of resonances is limited
when using only direct editing for the 1H attached to 13C.
For example, the C2 resonances of Glu and glutamine are
not easily separated in the 1H spectra (Fig. 1B), whereas in
13C NMR spectra even at 4 T as shown in Fig. 2 (Gruetter
et al., 1998a; Gruetter et al., 2001), and to some extent at 1.5
and 2.1 T, the C2 of Glu and glutamine are readily separated
(Bluml, 1999; Gruetter, 1993; Shen et al., 1999).
3. The 13C glucose labeling studies of the brain
Most 13C NMR studies of the brain are designed along
the principles of tracer studies, and as a matter of fact the
mathematics involved are not different in substance. How-
ever, because of the low sensitivity of MR and the non-toxic
nature of using the natural substrate, such as glucose, the
label is administered in quantities that increase the isotopic
enrichment well above what can be considered tracer level
and isotopic enrichments ranging between 50 and 100% are
not uncommon.
A majority of studies have focused on measuring Glu
turnover (Hyder et al., 1997; Lukkarinen et al., 1997; Pan
et al., 2000; Rothman et al., 1992), which was motivated by
the fact that cerebral Glu is linked to the metabolism of the
Krebs cycle (Chatham et al., 1995; Cruz and Cerdan, 1999;
Gruetter et al., 1998a; Gruetter et al., 2001; Mason et al.,
1995; Mason et al., 1992b; Yu et al., 1997), and that the Glu
C4 resonance, which is labeled in the first turn of the Krebs
cycle, presents a readily detectable NMR signal due to the
high concentration of Glu in the CNS.
4. Glucose transport
Unless glucose is injected directly into the brain, the label
must cross the blood–brain barrier before it is metabolized
by the brain cells. Aside from lactate and possibly glycogen
(Choi et al., 1999), glucose is the only sizable kinetic pool
in the Embden–Meyerhof pathway that is capable of influ-
encing the labeling kinetics of pyruvate and thus ultimately
of acetyl-CoA. Therefore, precise knowledge of the size of
the brain glucose pool and its physical distribution space is
critical for the derivation of absolute fluxes from, e.g. Glu
labeling curves. Many studies have measured the kinetics
of glucose transport (Knudsen et al., 1990; Pardridge, 1994;
Van Zijl et al., 1997) given that the dominant method to
measure cerebral glucose consumption is by measuring the
activity accumulated in the phosphorylation product of a
glucose analog, such as the widely used autoradiography
of deoxyglucose, or the non-invasive fluoro-deoxy-glucose
positron emission tomography (Tyler et al., 1988). In vivo
NMR spectroscopy stands out among these methods in
that it can provide a direct, localized measurement of brain
glucose content (Choi et al., 2001; Gruetter et al., 1992a;
Gruetter et al., 1998b) as well as the diffusion behavior of
glucose (Pfeuffer et al., 2000). The diffusion behavior of glu-
cose and lactate was found to be different from that of known
intracellular metabolites such as NAA, creatine and Glu. The
differential diffusion behavior was ascribed to the signal
component in extracellular space and comparison with
intracellular signals was used to estimate the physical dis-
tribution space of glucose (Pfeuffer et al., 2000). From the
relationship between brain and plasma glucose, steady-state
glucose transport kinetics can be derived (Choi et al., 2001;
Gruetter et al., 1992a; Gruetter et al., 1998b; Mason et al.,
1992a). Based on previous modeling it has been argued
that the turnover of brain glucose is too rapid to be able
to significantly influence labeling kinetics of the large Glu
pool (Mason et al., 1992a). However, based on numerical
simulations we have found this to be only true when the
changes in Glu labeling kinetics are large. When observing
rather small changes in brain Glu turnover, it is quite possi-
ble that these changes can be due to changes in flux through
the Embden–Meyerhoff pathway, which can influence the
rate of labeling of pyruvate, which ultimately is reflected
in a changed rate of fractional labeling of acetyl-CoA. In
other words, it is in principle possible to observe a change
in the labeling of Glu, even though the flux through pyru-
vate dehydrogenase has not changed. The question arises
as to whether such a difference in the labeling rate can af-
fect the Glu turnover curves and this question is addressed
in Fig. 3, which illustrates the simulated labeling curves
of Glu C4 assuming a 50% increase in flux through the
Embden–Meyerhof pathway (solid line) compared to resting
metabolism (dashed line), while all other metabolic rates
Fig. 3. Effect of increased rate of labeling of pyruvate due to increased
flux through glycolysis. The dashed line represents the rate of label
incorporation into Glu C4 at rest and the solid line the rate of label
incorporation, when assuming that glycolysis increased by 50% (Fox
et al., 1988) and all other fluxes remained unchanged.
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were held constant. In other words, if the observed changes
in Glu labeling are small, it is not clear whether they are
attributed to a large change in the Embden–Meyerhoff
pathway and small changes in oxidative metabolism, as
they have been reported (Fox et al., 1988) or whether the
changes are due to smaller fractional changes in oxidative
metabolism tightly coupled to glucose consumption. In
mathematical terms, this ambiguity results in a negative
numerical covariance of CMRglc and flux through pyruvate
dehydrogenase, VPDH. However, when large changes in
oxidative metabolism are observed, this covariance can be
expected to be much smaller to the point that it may even be
irrelevant. Several-fold changes in Glu turnover have been
reported during forepaw stimulation (Hyder et al., 1996;
Hyder et al., 1997), and when such large changes occur,
the increased turnover rate of the cerebral glucose pool is
expected to have a lower relative influence.
Glucose is the single most important substrate for nor-
mal function, and the brain relies on a continuous import
of glucose from the blood, which must occur across the
blood–brain-barrier. Glucose transport rates into the brain
Fig. 4. Direct detection of brain glycogen metabolism, adapted from Choi et al., 1999. (A) Rapid mobilization of glycogen and glucose is illustrated with
a horizontal stack plot of 13C NMR spectra before and after inducing hypoxic ischemia by intravenous KCl injection at t = 0 min. The spectra are from
a 500l volume and were collected at 9.4 T with a 90 s temporal resolution. The arrows indicate the position of the glycogen resonance. (B) During
(1-13C) glucose infusion, the 13C glucose signal rises rapidly (right scale), leading to label transfer into glycogen (left scale). Following the infusion
with unlabeled (cold) glucose (pulse-chase experiment), the glucose label is rapidly washed out leading to a much slower reduction in brain glycogen
signal implying a slow turnover of glycogen under resting conditions.
thus are indicative of the maximal sustainable rate of glu-
cose consumption, CMRglc. We have recently shown in
the conscious human and the -chloralose anesthetized rat,
that the maximal sustainable rate of glucose consumption
is approximately 60–90% above the basal rate of glucose
metabolism (Choi et al., 2001; Gruetter et al., 1998b).
Recent studies by Hyder et al. have reported that over a
45 min period of forepaw stimulation, oxidative glucose
metabolism was increased by more than three-fold (Hyder
et al., 1996; Hyder et al., 1997). Such an increase in cere-
bral glucose metabolism is clearly beyond what transport
across the blood–brain barrier can sustain alone and the
implication is that other sources of fuel must have been
increasingly utilized.
5. Brain glycogen, the forgotten energy store
As pointed out in the previous section, some of the
reported increases in brain glucose metabolism ob-
served during focal activation imply increased usage of
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carbohydrates other than blood glucose. One such source
of glucose equivalents is brain glycogen, which is present
in sizable amounts in brain (Choi et al., 1999). It remains
to be determined whether the changes reported by Hyder
et al. are accounted for by brain glycogen alone. Studies
have reported that brain glycogen metabolism appears to be
activated during focal stimulation (Swanson, 1992). Brain
glycogen metabolism and concentrations obviously can be
measured by NMR (Choi et al., 2000; Choi et al., 1999).
Based on the high metabolic activity of the brain, label
wash-in and wash-out was expected to be fast. However,
such pulse-chase experiments clearly demonstrated that
glycogen phosphorylase in the -chloralose anesthetized rat
was very slow, on the order of 0.5mol/(g h) during glucose
infusions, as illustrated by the slow label washout during
the chase in Fig. 4A. Clearly, as illustrated in Fig. 4B,
the brain glycogen reservoir was rapidly mobilized during
global ischemia combined with hypoxia and the question
arises as to what is the mechanism by which brain glycogen
concentrations are controlled. One possibility is that glyco-
gen, like in other tissues, is a reservoir of glucosyl units
that is mobilized when there is demand in excess of glucose
supply. During global ischemia, we indeed observed that
depletion of brain glycogen occurred on a time scale com-
parable to that of brain glucose (Fig. 4B), which supported
the view that glycogen appears to be a glucosyl reservoir,
of probably limited storage capability. To further test this
hypothesis, we studied the effect of profound hypoglycemia
on brain glycogen. Textbook literature implies that brain
glycogen is a limited storage form for glucose and based on
that reasoning its role as a glucose reservoir has been dis-
missed. However, during hypoglycemia, glycogen need only
account for part of the deficient glucose supply and hence
can survive longer periods of sustained hypoglycemia. Our
results showed that brain glycogen indeed was only slowly
degraded during hypoglycemia and that this degradation
started when brain glucose approached zero, which is the
point at which glucose transport becomes rate-limiting for
metabolism (Gruetter et al., 2000). Interestingly, at this
point cerebral blood flow was increased abruptly, indicating
an attempt by the brain to increase supply, by decreasing
the arterio–venous gradient for glucose (Choi et al., 2001).
We reported rates of label incorporation into glycogen using
the native glucose that were very similar to those observed
using deoxyglucose (Nelson et al., 1984), implying that the
rate of incorporation of deoxyglucose into glycogen is as
efficient as it is for glucose. These considerations raise the
interesting possibility that deoxyglucose measurements of
brain glucose metabolism can be affected by brain glycogen
metabolism in focal neural activation.
6. Glu turnover: oxygen metabolism
Because of the ever increasing importance of functional
MRI, which depends on an activation-dependent change in
the venous concentration of deoxyhemoglobin, the question
whether there is tight coupling between glucose and oxy-
gen consumption in the brain has become of paramount im-
portance. The landmark study by Fox and Raichle in the
late 1980s suggested that there is indeed a large increase
in glucose metabolism that exceeds the changes in oxygen
metabolism (Fox et al., 1988). The concept of uncoupled
oxygen metabolism has been supported by reports of small
increases in brain lactate during focal activation (Prichard
et al., 1991), that initially were very controversial (Merboldt
et al., 1992) and that are very difficult to perform. The rel-
atively small magnitude of change in brain lactate is diffi-
cult to reconcile with the reported large uncoupling between
oxygen and glucose consumption (Madsen et al., 1999). To
address this question, we performed a study to measure the
effect of focal activation on cerebral Glu turnover. This was
achieved using the following study design: Using hemi-field
activation, we verified that only one side of the human vi-
sual cortex was activated. Measurement of Glu turnover was
then performed in this area and simultaneously in a control
area placed symmetrically to the midline, which was veri-
fied to be devoid of activated pixels. Comparison of the rate
of label incorporation indicated a significant difference be-
tween the activated and the resting voxel. Modeling of the
data (Fig. 5) indicated that oxygen consumption increased at
most by 30%, which is approximately half of the blood flow
increase measured using this stimulation paradigm (Chen
et al., 2001). Unfortunately, the change in Glu turnover was
small enough to be influenced by changes in brain glucose
turnover as illustrated by the discussion above and by the
simulation presented in Fig. 3, and thus an unambiguous
answer was not possible. Nevertheless, this study supports
Fig. 5. Focal brain activation of the human brain. Shown is the average
label incorporation curve into brain Glu from five studies. The solid
squares are the measurements from the activated side, and the open
squares are the resting half of the human visual cortex during hemifield
stimulatioin. Adapted from Chen et al., 2001. The solid line shows the
fit of a model of brain metabolism similar to what is shown in Fig. 6A
and the dashed line is the fit to the data obtained from the resting visual
cortex. The small changes in Glu labeling indicate at most a 30% increase
in Glu labeling.
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Table 1
Relative fluxes in human visual cortex as measured by 13C NMR following
glucose infusion (from Gruetter et al., 2001)
Relative flux rate (%)
VNT/CMRglca 41 ± 14
Oxidative ATP/total ATP production in glia 80 ± 5
Glial/neuronal ATP synthesis 16 ± 9
Vx/VPDH 100 ± 35
a For a definition of fluxes see Fig. 6B and (Gruetter et al., 2001).
the idea that oxygen consumption increases are less than the
associated blood flow increases, leading to a net decrease
in deoxy-hemoglobin content during focal activation, which
forms the basis of blood-oxygen-level-dependent functional
MRI (Ogawa et al., 1998).
Measurements of Krebs cycle flux from the flow of la-
bel from glucose C1 to Glu C4 are inherently affected by
the assumptions made in the modeling. Of critical impor-
tance in that regard is the fact that most amino acids are
located in the cytosol, whereas the reactions leading to the
scrambling of the label take place in the mitochondrion.
Therefore, transport has to occur across the highly charged
inner mitochondrial membrane. It is likely that the transport
of Glu (a charged amino acid, whose transport is generally
associated with concomitant ion transport) or oxoglutarate
(an acid as well) is controlled, since rapid transport of these
acids is likely to interfere with chemiosmosis. In brain and
other tissues, exchange does occur via the malate–aspartate
shuttle (illustrated by the scheme in Fig. 6A) and our ob-
servation that Vx is comparable to the flux through pyruvate
dehydrogenase (Table 1) implies that the malate–aspartate
shuttle may be a major mechanism mediating the exchange
of label across the mitochondrial membrane (LaNoue and
Tischler, 1974). It is in this context also important to rec-
ognize that the pool size that is in exchange with the Krebs
cycle intermediate can also affect the accuracy by which the
labeling of the amino acid represents that in the Krebs cycle.
Table 2 illustrates that the calculation of VPDH from aspar-
tate labeling is much less prone to the specific assumption
made for Vx, which in part reflects the fact that aspartate
is approximately four–six times less concentrated in brain
than is Glu.
Table 2
Krebs cycle flux (VPDH)a as a function of the rate of exchange, Vx,
measured from Asp (Asp23) or Glu C4 (Glu4)
Vx (mol/(g min)) Asp23 Glu4
57 1.04 0.53
10 1.04 0.55
2 1.03 0.65
1 1.01 0.83
0.75 1.00 1.00
a Obtained by fitting Vout and VPDH keeping the remainder of the
fluxes fixed and by dividing the values by the VPDH obtained at V x =
0.75mol/(g min), reproduced from Gruetter et al., 2001.
7. Glutamine turnover: The hallmark of cerebral
compartmentation
Brain metabolism is exquisitely compartmentalized,
with at least two major compartments (attributed to the
“neuronal” and “glial” compartment) that are differenti-
ated by the size of the respective Glu pools associated
with the Krebs cycle and that are metabolically linked
by the Glu–glutamine cycle (Yudkoff et al., 1993). It
has now become accepted that the large Glu pool is in
the neuronal compartment and the small Glu pool in the
glial compartment. The compartmentation extends further
to a number of enzymes, such as glutamine synthetase
(Martinez-Hernandez et al., 1976) and pyruvate carboxylase
(Shank et al., 1985) being almost exclusively in the glial
compartment. Furthermore, glycogen appears to be mainly
in the glial compartment in normal adult brain (Dringen
et al., 1993). The compartmentation of brain metabolism
and associated enzymes is summarized in more detail else-
where (Bachelard, 1998; Cruz and Cerdan, 1999; Gruetter
et al., 2001). The scheme in Fig. 6B summarizes some of
the salient features that can be exploited in modeling brain
metabolism. It is of interest to note that the exclusively
glial localization of glutamine synthetase implies that the
observation of glutamine synthesis in vivo, first achieved
in human brain (Gruetter, 1993; Gruetter et al., 1994), is a
direct manifestation of glial metabolism, whereas the ob-
servation of label incorporation into Glu implies a mainly
neuronal event. Clearly, glutamine synthesis can be mea-
sured non-invasively by NMR, as shown in Figs. 1 and
2, and therefore implicates the ability of NMR to study
cerebral compartmentation non-invasively.
A key feature to cerebral compartmentation is the inacti-
vation of neurotransmitter Glu by uptake into perisynaptic
astrocytes and conversion into electrophysiologically inac-
tive glutamine (Daikhin and Yudkoff, 2000; McKenna et al.,
2000; Nicklas et al., 1987; Schousboe et al., 1993). Clearly,
this mechanism implies a much more active role for astro-
cytes than is conventionally assumed, since the conversion
of neurotransmitter Glu to glutamine invokes glial energy
metabolism (Eriksson et al., 1995; Magistretti and Pellerin,
1996; Silver and Erecinska, 1997). The neuron–astrocyte
pair thus has to be considered the functional unit intimately
involved in achieving chemical transmission which has
been proposed in the last decade by Magistretti and others
(Magistretti et al., 1999; Magistretti et al., 1993; Tsacopou-
los and Magistretti, 1996). The link between astrocytes and
neurons is generally accepted from a metabolic and from
a neurophysiological standpoint (Bergles et al., 1997), yet
differences exist as to the precise coupling and the specific
energetics involved.
For example, a recent proposal suggested that the
rate of Glu–glutamine inter-conversion (also termed the
“Glu–glutamine cycle”), identified in the scheme in Fig. 6A
by V appNT , is equal to the glucose consumption rate (Sibson
et al., 1998). The proposed near 1:1 stoichiometry
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Fig. 6. (A) The link between oxidative glucose consumption and Glu labeling is established by active exchange between oxoglutarate (OG) and Glu,
this flux is indicated by Vx. Exchange between 2-oxoglutarate and Glu, Vx, on one hand, and oxaloacetate and aspartate on the other hand is mediated
by the malate–aspartate shuttle, which involves several reactions, which are detailed in the dashed box. Vx in (B) thus represents the combination of
multiple reactions, one of which is transport across the inner mitochondrial membrane. The function of the malate–aspartate shuttle is to transport
reducing equivalents produced from the cytosol to the mitochondrion thereby maintaining the cytosolic redox potential under normoxic conditions. (B) A
mathematical model of compartmentalized brain metabolism, from Gruetter et al., 1998a; Gruetter et al., 2001. The glial compartment is on the left and
the neuronal on the right. Abbreviations for metabolic fluxes: CMRglc, glucose consumption; VPDH, neuronal Krebs cycle; VPC, pyruvate carboxylase;
V g+V PC, glial pyruvate dehydrogenase; Vx, exchange between cytosolic amino acids and mitochondrial Krebs cycle intermediates; Vsyn, Gln synthetase;
V
app
NT , apparent rate of Glu neurotransmission; Vefflux, loss of Gln from the glial compartment; Vout , Vlout , label dilution and exchange of lactate across
the blood–brain barrier. Abbreviations for metabolites: Glc, glucose; Glyc, glycogen; Glc-6-P, glucose-6-phosphate; Pyr, pyruvate; Lac, lactate; OAA,
oxaloacetate; OG, 2-oxoglutarate; Asp, aspartate; Gln, glutamine; The metabolites in boldface are the signals measurable by NMR in vivo. The subscripted
numerals indicate the positions labeled due to metabolism of glucose labeled at the C1 position, i.e. Glc1.
between glucose consumption to the flux of Glu into glu-
tamine, however, implied that the two ATP produced in
the Embden-Meyerhor pathway are almost completely
consumed by glutamine synthesis and restoration of the
ion balance through the Na/K ATPase. This scheme is
illustrated in Fig. 7A, and the implication is that under
isoelectricity, energy metabolism is essentially turned off.
Our recent measurements (summarized in Table 1) imply
that even when assuming that changes in Glu neurotrans-
mission result in a 1:1 stoichiometric change of glucose
metabolism with V appNT (which is different from what has
been proposed in (Sibson et al., 1998)), glucose metabolism
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Fig. 7. Stoichiometry of glutamatergic action. The implications of the model proposed by Shulman et al. (A) The 1:1 stoichiometry between CMRglc and
V
app
NT proposed recently. In this model it is assumed that the two ATP required for the Na/K ATPase to restore the ion balance after glutamate uptake and
for glutamine synthesis are produced exclusively by the Embden–Meyerhof pathway as proposed (Magistretti et al., 1999; Rothman et al., 1999; Sibson
et al., 1998), which neglects oxidative generation of ATP (dashed arrows). (B) Energetics of anaplerotic glutamine synthesis from glucose in the glial
compartment. Reactions yielding ATP through oxidative phosphorylation are indicated by the subscript NADH. These include glyceraldehyde-3-phosphate
dehydrogenase, pyruvate dehydrogenase and isocitrate dehydrogenase. One glucose forms two pyruvate and in that process two ATP; one ATP is
consumed by the consumption of one pyruvate to form oxaloacetate. Net synthesis of citrate is followed in this scheme by net removal of 2-oxoglutarate
to form glutamine, which requires an additional ATP per glutamine molecule formed, thereby maintaining a constant concentration of glial Krebs cycle
intermediates. For abbreviations, see also caption of Fig. 6.
at V NT = 0 (“isoelectricity”) is approximately half of that at
normal resting conditions, which is in good agreement with
reported decreases in oxygen consumption during isoelec-
tric pentobarbital anesthesia in humans. The proposal put
forth by Shulman et al. (Rothman et al., 1999; Sibson et al.,
1998), that the glial ATP production needed to maintain
neuronal Glu is solely provided by the Embden–Meyerhoff
pathway is intriguing as it emphasizes the coupling between
neurons and glia at the level of energy metabolism. How-
ever, only a few percent of pyruvate need to be diverted to
the Krebs cycle to generate as many ATP as are formed in
the absence of oxidative metabolism of glucose in the as-
trocytes (aerobically generation of ATP is illustrated by the
dashed arrows in Fig. 7A). Astrocytes clearly have oxygen
metabolism (Eriksson et al., 1995), and this shall be fur-
ther exemplified in the case of anaplerosis, a mitochondrial
reaction confined to the glial compartment. The energetics
of glutamine synthesis from glucose via anaplerosis imply
substantial oxidative ATP generation: As illustrated in the
scheme in Fig. 7B, almost 10 ATP are generated per glu-
tamine molecule synthesized due to the reducing equivalents
produced by glycerol-3-phosphate dehydrogenase, pyruvate
dehydrogenase and isocitrate dehydrogenase. Pyruvate car-
boxylase activity is significant in vivo (Gruetter et al., 1998a;
Gruetter et al., 2001; Lapidot and Gopher, 1994; Shen et al.,
1999). This calculation assumed a P:O ratio of 2.5:1, when
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assuming a P:O ratio of 3:1 as in previous studies (Sibson
et al., 1998), almost 12 ATP are generated per glutamine
molecule, which is approximately a third as efficient as
complete glucose oxidation, yet five–six times as efficient
as anaerobic glycolysis alone. Although differences exist as
to the magnitude of the flux through pyruvate carboxylase,
the labeling pattern is different between glutamine and Glu
(Gruetter et al., 1998a; Gruetter et al., 2001; Lapidot and
Gopher, 1994; Martin et al., 1993), which implies substan-
tial contribution of pyruvate carboxylase to the flux through
glutamine synthetase. Even the lowest reported value of
0.04mol/(g min) (Shen et al., 1999) results in an ATP gen-
eration of 0.4mol/(g min), which corresponds to 50–75%
of the ATP needed for Glu uptake and conversion to glu-
tamine (Gruetter et al., 1998a; Gruetter et al., 2001). Adding
the small glial Krebs cycle flux of ∼0.04mol/(g min) re-
sults in a rate of oxidative ATP production well in excess
of what is required for the Glu–glutamine interconversion,
which is in agreement with the observation that under basal
conditions the energy requirements of the Na/K ATPase
are 20% of the ATP synthesized in astrocytes (Silver and
Erecinska, 1997). Given that autoradiographs are acquired
typically following extended periods of tracer adminis-
tration, it is unlikely that in such periods of activation,
glial cells do not increase their oxygen consumption. In
fact, oxygen consumption has been reported to increase
in cultured astrocytes when exposed to extracellular Glu
(Eriksson et al., 1995) and large increases in oxygen con-
sumption have been reported (Hyder et al., 1996; Hyder
et al., 1997), which support the idea that oxygen metabolism
in astrocytes is stimulated during focal activation. It should
be stressed that the concept of oxidative metabolism still is
compatible with the idea that lactate produced in astrocytes
is the fuel for oxidative metabolism in neurons. Our results
suggest that in the human brain approximately one sixth
of the ATP production from glucose measured by NMR is
in the glial compartment, leaving five-sixths of the lactate
for export to neurons, when assuming the extreme case that
phosphorylation of glucose is an exclusively glial process.
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